Abstract: An organometallic compound represented by Formula 1: M1(L1)n1(L2)n2??Formula 1 wherein, M1 is a transition metal, L1 is a ligand represented by Formula 1A, L2 is a ligand represented by Formula 1B, and n1 and n2 are each independently 1 or 2, wherein X1 is C or N; X2 is C or N; X3 is C or N; X4 is C or N; ring CY1 and ring CY2 are each independently a C5-C30 carbocyclic group or a C1-C30 heterocyclic group; Z1 and Z2 are each independently —Si(Q1)(Q2)(Q3) or —Ge(Q1)(Q2)(Q3); a1 and a2 are each independently an integer from 0 to 10; a sum of a1 and a2 is 1 or greater; and the remaining substituent groups are as described herein.

Abstract: An organometallic compound represented by Formula 1: M1(L1)n1(L2)n2??Formula 1 wherein, M1 is a transition metal, L1 is a ligand represented by Formula 1A, L2 is a ligand represented by Formula 1B, and n1 and n2 are each independently 1 or 2, wherein X1 is C or N; and X2 is C or N; Y1 is O, S, or Se; ring CY1 is a C5-C30 carbocyclic group or a C1-C30 heterocyclic group; * and *? each indicate a binding site to M1; and the remaining substituent groups are as defined herein.

Abstract: An organometallic compound represented by Formula 1A: wherein, in Formula 1A, groups and variables are the same as described in the specification.

Abstract: An organometallic compound represented by Formula 1: M1(L1)n1(L2)n2??Formula 1 wherein, in Formula 1, M1 is a transition metal, L1 is a ligand represented by Formula 1A, L2 is a ligand represented by Formula 1B, and n1 and n2 are each independently 1 or 2: wherein, X1 is C or N, X2 is C or N, Y1 is O, S, Se, C(R41)(R42), or N(R43), at least one R2 is a C1-C10 alkyl group that is substituted with a fluorine, b2 is an integer from 1 to 6, b11 is 1 or 2, b12 is an integer from 1 to 4, * and *? each indicate a binding site to M1, and the other substituent groups in Formulae 1A and 1B are as described herein.

Abstract: A light-emitting device including a first electrode, a second electrode opposing the first electrode, and an interlayer located between the first electrode and the second electrode, wherein the interlayer includes an emission layer, wherein the emission layer includes m1 dopants and m2 hosts, and m1 and m2 are each 1 or greater, when m1 is 2 or greater, then two or more of the dopants are different from each other, when m2 is 2 or greater, then two or more of the hosts are different from each other, and the light-emitting device satisfies Condition 1: 0 debye·V?DMEML×(Vop?Vinj)?3.41 debye·V??Condition 1 wherein Condition 1 may be understood by referring to the description provided herein.

Abstract: An organometallic compound represented by Formula 1: M1(L1)n1(L2)n2??Formula 1 wherein, M1 is a transition metal, L1 is a ligand represented by Formula 1A, L2 is a ligand represented by Formula 1B, and n1 and n2 are each independently 1 or 2, wherein X1 is C or N, X2 is C or N, at least one R2 is a C1-C10 alkyl group that is substituted with a fluorine, b1 is an integer from 1 to 6, b2 is an integer from 1 to 10, * and *? each indicate a binding site to M1, and the other substituent groups of Formulae 1A and 1B are as described herein.

Abstract: An organometallic compound represented by Formula 1: M1(L1)n1(L2)n2??Formula 1 wherein, M1 is a transition metal, L1 is a ligand represented by Formula 1A, and L2 is a ligand represented by Formula 1B, and n1 and n2 are each independently 1 or 2, wherein X1 and X2 are each independently C or N, Y1 is O, S, Se, C(R5)(R6), or N(R7), X44 is N or C(R44), X45 is N or C(R45), X46 is N or C(R46), and X47 is N or C(R47), and the other substituent groups are as defined herein.

Abstract: A composition, including m1 dopants; and m2 hosts, wherein m1 and m2 are each an integer of 1 or greater, when m1 is 2 or greater, two or more of the m1 dopants are different from each other, when m2 is 2 or greater, two or more of the m2 hosts are different from each other, and the composition has an image-modifying coordinate represented by: (X,Y) as defined herein.

Abstract: An organometallic compound represented by Formula 1: M1(L1)n1(L2)n2??Formula 1 wherein M1 is a transition metal, L1 is a ligand represented by Formula 1A, L2 is a ligand represented by Formula 1B, and n1 and n2 are each independently 1 or 2, wherein X1 and X2 are each independently C or N, ring CY2 and ring CY4 are each independently a C5-C30 carbocyclic group or a C1-C30 heterocyclic group, ring CY3 is a 5-membered heterocyclic group; a 5-membered heterocyclic group condensed with a C5-C30 carbocyclic group; or a 5-membered heterocyclic group condensed with a C1-C30 heterocyclic group, Y1 is O, S, Se, C(R5)(R6), N(R7), Si(R8)(R9), or Ge(R8)(R9), at least one of R12 and R13 comprises deuterium, and the other substituent groups are as described herein.

Abstract: An organometallic compound represented by Formula 1: M1(L1)n1(L2)n2??Formula 1 wherein M1 is a transition metal, L1 is a ligand represented by Formula 1A, L2 is a ligand represented by Formula 1B, and n1 and n2 are each independently 1 or 2, wherein X1 to X4 are each independently C or N, Y1 is O, S, Se, C(R5)(R6), N(R7), or Si(R8)(R9), ring CY2 and ring CY4 are each independently a C5-C30 carbocyclic group or a C1-C30 heterocyclic group, ring CY3 is a 6-membered heterocyclic group, a 6-membered heterocyclic group condensed with a C5-C30 carbocyclic group, or a 6-membered heterocyclic group condensed with a C1-C30 heterocyclic group, Z1 comprises at least one deuterium, and the other variables are as provided herein.

Abstract: An organometallic compound represented by Formula 1: M1(Ln1)n1(Ln2)n2??Formula 1 wherein M1 is a transition metal, Ln1 is a ligand represented by Formula 1-1, Ln2 is a bidentate ligand, n1 is 1, 2, or 3, and n2 is 0, 1, or 2, wherein X1, X2, X11 to X14, Y1, R10, R20, ring CY2, b10, and b20 are as defined herein, and wherein * and *? each indicate a binding site to M1.

Abstract: An organometallic compound represented by Formula 1: M(L1)3??Formula 1 wherein M is iridium, and L1 is a ligand represented by Formula 2-1 or a ligand represented by Formula 2-2, wherein Y1 is N, X11 is C(R11) or N, X12 is C(R12) or N, X1 is O, S, or N-{(T1)b1-(Z1)c1}, T1 is a single bond, a C1-C20 alkylene group that is unsubstituted or substituted with at least one R10a, a C5-C30 carbocyclic group that is unsubstituted or substituted with at least one R10a, or a C1-C30 heterocyclic group that is unsubstituted or substituted with at least one R10a, A1 to A4 are each independently C or N, wherein one of A1 to A4 is C bonded to an adjacent 5-membered ring, and another of A1 to A4 is C bonded to M in Formula 1, and the remaining substituent groups are as defined herein.

Abstract: An organometallic compound represented by Formula 1: M1(L1)n1(L2)n2??Formula 1 wherein, M1 is a transition metal, L1 is a ligand represented by Formula 1A, L2 is a ligand represented by Formula 1B, and n1 and n2 are each independently 1 or 2, wherein X1 is C or N, and X2 is C or N, b1 is an integer from 1 to 6, b2 is an integer from 1 to 8, * and *? each indicate a binding site to M1 in Formula 1, and the remaining substituent groups are as described herein.

Abstract: A heterocyclic compound represented by Formula 1: wherein E1 is a group represented by Formula A; k1 is an integer from 1 to 5; n1 is 2 or 3; n2 is an integer from 0 to 3; d1, d2, d3, d5, and d6 are each independently an integer from 0 to 4; d4 is an integer from 0 to 3; d7 is an integer from 0 to 5; wherein the heterocyclic compound represented by Formula 1 comprises at least one deuterium; * indicates a binding site to an adjacent atom; and the remaining substituents are as defined herein.

Abstract: An organometallic compound represented by Formula 1: M1(L1)n1(L2)n2??Formula 1 wherein, M1 is a transition metal, L1 is a ligand represented by Formula 1A, L2 is a ligand represented by Formula 1B, and n1 and n2 are each independently 1 or 2, wherein X1 is C or N; X2 is C or N; X3 is C or N; X4 is C or N; ring CY1 and ring CY2 are each independently a C5-C30 carbocyclic group or a C1-C30 heterocyclic group; Z1 and Z2 are each independently —Si(Q1)(Q2)(Q3) or —Ge(Q1)(Q2)(Q3); a1 and a2 are each independently an integer from 0 to 10; a sum of a1 and a2 is 1 or greater; Y1 and Y2 are each independently O, S, Se, N(R51), B(R52), C(R53)(R54), Si(R55)(R56), or Ge(R57)(R58); and the remaining substituent groups are as described herein.

Abstract: Provided are an etching composition including an oxidizing agent, an ammonium salt, an aqueous solvent, and an accelerator, a method of preparing a metal-containing film etching by using the same, and a method of manufacturing a semiconductor device by using the same.

Abstract: An organometallic compound represented by Formula 1: M1(L1)n1(L2)n2??Formula 1 wherein, M1 is a transition metal, L1 is a ligand represented by Formula 1A, L2 is a ligand represented by Formula 1B, and n1 and n2 are each independently 1 or 2, wherein, X1 to X4 are each independently C or N, ring CY1 and ring CY2 are each independently a C6-C30 carbocyclic group or a C1-C30 heterocyclic group, Z1 and Z2 are each independently —Si(Q1)(Q2)(Q3) or —Ge(Q1)(Q2)(Q3), a1 and a2 are each independently an integer from 0 to 10, a sum of a1 and a2 is 1 or greater, Y1 is O, S, Se, C(R51)(R52), or N(R53), Y2 is O, S, Se, C(R61)(R62), or N(R63), * and *? each indicate a binding site to M1, and the other substituent groups are as described herein.

Abstract: An organometallic compound represented by Formula 1 and an organic light-emitting device including the same: Y2, ring A2, R1 to R8, R13 to R20, and d2 in Formula 1 may be each independently the same as described in the specification.

Abstract: An organometallic compound represented by Formula 1: M1(L1)n1(L2)n2??Formula 1 wherein, M1 is a transition metal, L1 is ligand represented by Formula 1A, L2 is a ligand represented by Formula 1B, and n1 and n2 are each independently 1 or 2: wherein X1 to X4 are each independently C or N; Y1 is O, S, Se, C(R5)(R6), N(R7), or Si(R8)(R9); ring CY2 and ring CY4 are each independently a C5-C30 carbocyclic group or a C1-C30 heterocyclic group; ring CY3 is a 5-membered heterocyclic group, a 5-membered heterocyclic group condensed with a C5-C30 carbocyclic group, or a 5-membered heterocyclic group condensed with a C1-C30 heterocyclic group; * and *? each indicate a binding site to M1; and the remaining descriptions of Formulae 1A and 2B as described herein.

Abstract: An organometallic compound represented by Formula 1: M(L1)n1(L2)n2??Formula 1 wherein M is a transition metal, L1 is a ligand represented by Formula 2-1, L2 is a ligand represented by Formula 2-2 or a ligand represented by Formula 2-3, n1 and n2 are each independently 1 or 2, when n1 is 2, two L1 are identical to or different from each other, and when n2 is 2, two L2 are identical to or different from each other, and L1 and L2 are different from each other, wherein the groups in Formulae 2-1, 2-2, and 2-3 are each independently as described herein.